Data: Carbon Brief, IEA and UNEP; Note: Carbon Brief analysis projects COVID-19 impact, IEA shows current emissions pathway, and UNEP’s “emissions gap” report shows needed path for the Paris Agreement’s goals; Chart: Naema Ahmed/Axios

Global carbon emissions are projected to drop an unprecedented 5.5% this year, according to an analysis by Carbon Brief, a website on climate change and energy.

Yes, but: They'll need to fall a lot more than that — not just in total, but even on an annual basis. The 2015 Paris Agreement is designed to keep global temperatures rising no more than 1.5°C over the coming decades. That would require an annual 7.6% drop in emissions.

The bottom line: A global pandemic is the worst possible way to reduce carbon emissions. Even an enormous fall in economic activity doesn't naturally reduce emissions by as much as is needed.

  • If you thought the recent 90% reduction in international travel might do the trick, consider yourself disabused. Any workable solution is going to have to be able to accommodate growth, rather than calling for shrinking the economy.

Go deeper

Ben Geman, author of Generate
Jul 28, 2020 - Energy & Environment

EPA watchdog puts new scrutiny on Trump's auto emission rules

Illustration: Sarah Grillo/Axios

The EPA's internal watchdog is opening a probe into how the agency wrote controversial rules that weakened Obama-era carbon emissions standards for cars and light trucks.

Why it matters: The Obama-era emissions and mileage standards that extended into the mid-2020s were a pillar of the former president's climate change agenda.

Supreme Court Justice Ruth Bader Ginsburg dies at 87

Ruth Bader Ginsburg. Photo: Tom Brenner/Getty Images

Justice Ruth Bader Ginsburg has died of metastatic pancreatic cancer at age 87, the Supreme Court announced Friday evening.

Why it matters: Ginsburg had suffered from serious health issues over the past few years. Her death sets up a fight over filling a Supreme Court seat with less than 50 days until the election.

NYT: White House drug price negotiations broke down over $100 "Trump Cards"

President Trump with Mark Meadows, his chief of staff, on Sept. 3 at Andrews Air Force Base in Maryland. Photo: Mandel Ngan/AFP via Getty Images

Negotiations on a deal between the White House and pharmaceutical industry to lower drug prices broke down last month after Mark Meadows, the president's chief of staff, insisted that drugmakers pay for $100 cash cards to be mailed to seniors before the election, according to the New York Times.

Why it matters: Some of the drug companies feared that in agreeing to the prescription cards — reportedly dubbed "Trump Cards" by some in the pharmaceutical industry — they would boost Trump's political standing weeks ahead of Election Day with voters over 65, a group that is crucial to the president's reelection bid, per the Times.